Literature DB >> 16949804

Effect of drug type on the degradation rate of PLGA matrices.

Steven J Siegel1, Jonathan B Kahn, Kayla Metzger, Karen I Winey, Kathryn Werner, Nily Dan.   

Abstract

We compare the rate of drug release through the degradation of 50:50 polylactic-co-glycolic acid polymer pellets, for six different drugs: Thiothixene, Haloperidol, Hydrochlorothiozide, Corticosterone, Ibuprofen, and Aspirin. Despite using the same polymer matrix and drug loading (20% by weight), we find that the rate of polymer degradation and the drug release profile differ significantly between the drugs. We conclude that the design of biodegradable polymeric drug carriers with high drug loadings must account for the effect of the drug on the polymer degradation and drug release rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949804     DOI: 10.1016/j.ejpb.2006.06.009

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  29 in total

1.  Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits.

Authors:  Kayla L Metzger; Jody M Shoemaker; Jonathan B Kahn; Christina R Maxwell; Yuling Liang; Jan Tokarczyk; Stephen J Kanes; Meredith Hans; Anthony M Lowman; Nily Dan; Karen I Winey; Neal R Swerdlow; Steven J Siegel
Journal:  Psychopharmacology (Berl)       Date:  2006-11-21       Impact factor: 4.530

2.  Selective Nanoparticle Targeting of the Renal Tubules.

Authors:  Ryan M Williams; Janki Shah; Helen S Tian; Xi Chen; Frederic Geissmann; Edgar A Jaimes; Daniel A Heller
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

3.  Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release.

Authors:  Veronika Schmitt; Claudia Kesch; John K Jackson; Samir Bidnur; Eliana Beraldi; Virginia Yago; Mary Bowden; Martin E Gleave
Journal:  Pharm Res       Date:  2020-01-21       Impact factor: 4.200

4.  In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia.

Authors:  Laura C Amann; Michael J Gandal; Robert Lin; Yuling Liang; Steven J Siegel
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

5.  Application of time-resolved fluorescence for direct and continuous probing of release from polymeric delivery vehicles.

Authors:  Mathieu L Viger; Wangzhong Sheng; Cathryn L McFearin; Mikhail Y Berezin; Adah Almutairi
Journal:  J Control Release       Date:  2013-06-20       Impact factor: 9.776

6.  Electrospun PLGA Nanofiber Scaffolds Release Ibuprofen Faster and Degrade Slower After In Vivo Implantation.

Authors:  Corinne N Riggin; Feini Qu; Dong Hwa Kim; Julianne Huegel; David R Steinberg; Andrew F Kuntz; Louis J Soslowsky; Robert L Mauck; Joseph Bernstein
Journal:  Ann Biomed Eng       Date:  2017-06-26       Impact factor: 3.934

7.  A rapid method for creating drug implants: translating laboratory-based methods into a scalable manufacturing process.

Authors:  Cheng-Kuo Wang; Wan-Yi Wang; Robert F Meyer; Yuling Liang; Karen I Winey; Steven J Siegel
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-05       Impact factor: 3.368

8.  Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.

Authors:  Daniel J Hines; David L Kaplan
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2013       Impact factor: 4.889

9.  Effects of antibiotic physicochemical properties on their release kinetics from biodegradable polymer microparticles.

Authors:  Sarita R Shah; Allan M Henslee; Patrick P Spicer; Shun Yokota; Sophia Petrichenko; Sachin Allahabadi; George N Bennett; Mark E Wong; F Kurtis Kasper; Antonios G Mikos
Journal:  Pharm Res       Date:  2014-05-30       Impact factor: 4.200

Review 10.  Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review.

Authors:  Ashlee N Ford Versypt; Daniel W Pack; Richard D Braatz
Journal:  J Control Release       Date:  2012-10-26       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.